Anna Milton
Impact in
-
- Chronic Myeloid Leukemia Treatments
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Acute Lymphoblastic Leukemia research 7
-
- Chronic Myeloid Leukemia Treatments 7
- Co-authors
- David B. Konrad (2 shared papers)Gunnar Schotta (1 shared paper)Axel Imhof (1 shared paper)Sophia Groh (1 shared paper)Gustavo P. de Almeida (1 shared paper)Ignasi Forné (1 shared paper)Andreas Schmidt (1 shared paper)Fadi Haddad (4 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Blood (3 papers)Biological Chemistry (1 paper)HemaSphere (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
Anna Milton
9 papers receiving 60 citations
Peers
Comparison fields: 5 of 24
- Hematology 14
- Public Health, Environmental and Occupational Health 17
- Oncology 14
- Molecular Biology 33
- Virology 2
Countries citing papers authored by Anna Milton
This map shows the geographic impact of Anna Milton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Milton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Milton more than expected).
Fields of papers citing papers by Anna Milton
This network shows the impact of papers produced by Anna Milton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Milton. The network helps show where Anna Milton may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Milton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 33 | |
| 2 | 2022 | 8 | |
| 3 | 2022 | 5 | |
| 4 | 2022 | 5 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 2 | |
| 7 | 2021 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2025 | 0 |
About Anna Milton
Anna Milton is a scholar working on Public Health, Environmental and Occupational Health, Hematology, Genetics, Oncology and Molecular Biology, having authored 10 papers that have together received 60 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (7 papers), Acute Lymphoblastic Leukemia research (7 papers), Chronic Lymphocytic Leukemia Research (4 papers), CAR-T cell therapy research (2 papers), Ferroptosis and cancer prognosis (1 paper), Epigenetics and DNA Methylation (1 paper), Cancer-related molecular mechanisms research (1 paper) and Chromosomal and Genetic Variations (1 paper). The work is most often cited by research in Hematology (14 citations), Public Health, Environmental and Occupational Health (17 citations), Oncology (14 citations), Molecular Biology (33 citations) and Virology (2 citations). Anna Milton has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include David B. Konrad, Gunnar Schotta, Axel Imhof, Sophia Groh, Gustavo P. de Almeida, Ignasi Forné, Andreas Schmidt, Fadi Haddad, Juan J. Rivera and Elias Jabbour. Their work appears in journals such as Journal of Clinical Oncology, Blood, Biological Chemistry, HemaSphere and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.